Dr. Brittney H. Cotta, MD

Dr. Cotta practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Cotta's NPI, 1164806667, was assigned on July 14, 2015. Dr. Cotta graduated from SIU School of Medicine in 2015. Dr. Cotta holds Texas license U2814.

Dr. Cotta's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Cotta's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cotta practices. Vendor and product names are available with a free account.

Urology is Dr. Cotta's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cotta is board certified in urology by the American Board of Urology. Dmand AI has Dr. Cotta's licenses on file in 3 states: Texas, New York and California.

CMS data shows 46 Medicare services from Dr. Cotta across 3 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $4,468 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Cotta in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cotta's median patient age at 71, with 32% women.

In 2024, Dr. Cotta wrote 12 Medicare Part D claims. 92% of them were for generic drugs. They cover 2 drugs, with $536 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cotta for performance year 2024, reported as part of a group. Dr. Cotta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Cotta, published from 2015 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Antineoplastic Agents. Dr. Cotta has published most often in Clin Genitourin Cancer. Dr. Cotta's most frequent co-authors are Ithaar Derweesh, MD, Sunil H. Patel, MD and Stephen Thomas Ryan, MD.

CMS Open Payments shows 4 general payments to Dr. Cotta from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Endo Pharmaceuticals Inc. paid the most, $117.

Dr. Cotta graduated from SIU School of Medicine in 2015.

Dr. Cotta is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.